Managed Account Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

Managed Account Advisors’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$1.07M	Sell	23,279 -2,673	-10%	-$127K	﹤0.01%	2081
2015 Q1	$1.22M	Sell	25,952 -4,398	-14%	-$175K	﹤0.01%	2052
2014 Q4	$961K	Sell	30,350 -16,816	-36%	-$492K	﹤0.01%	2072
2014 Q3	$1.12M	Sell	47,166 -3,973	-8%	-$102K	﹤0.01%	2014
2014 Q2	$1.53M	Buy	51,139 +43,814	+598%	+$1.18M	﹤0.01%	1879
2014 Q1	$194K	Buy	7,325 +6,880	+1,546%	+$172K	﹤0.01%	2249
2013 Q4	$11K	Sell	445 -18,189	-98%	-$406K	﹤0.01%	2496
2013 Q3	$381K	Sell	18,634 -2,823	-13%	-$58.3K	﹤0.01%	2071
2013 Q2	$428K	Buy	+21,457	New	+$381K	﹤0.01%	2049

Other funds holding IPXL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Managed Account Advisors's IPXL Position: Q2 2015 in Review

Managed Account Advisors reduced its Impax Laboratories, Inc. (IPXL) stake by 10% in Q2 2015, selling an estimated $127K and leaving 23,279 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2081.

Managed Account Advisors first reported a position in IPXL in Q2 2013 and has held it in 9 quarters since. The position peaked at $1.53M in Q2 2014. 197 funds tracked by Wall St. Rank hold IPXL as of Q2 2015.

Managed Account Advisors held 23,279 shares of Impax Laboratories, Inc. worth $1.07M as of Q2 2015.
Managed Account Advisors sold 2,673 Impax Laboratories, Inc. shares in Q2 2015, an estimated $127K.
Impax Laboratories, Inc. made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2081 holding.
Managed Account Advisors first reported a position in Impax Laboratories, Inc. in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's Impax Laboratories, Inc. position peaked at $1.53M in Q2 2014.
197 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.